IPO Price History
Closed
Emcure Pharmaceuticals Limited logo

Emcure Pharmaceuticals Limited IPO

Mainboard IPOListedEMCURENSE
Current Market Price (CMP)
₹1,770.40(+75.63%)
Current Price (CMP)
₹1,770.40(+75.63%)

Live Market Quote

Listing Price & Gain
₹1,325.05(+31.45%)

Day 1 Exchange Open

IPO Issue Price
₹1,008

Band: ₹960 - ₹1008

Total Subscription
67.87x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
03 Jul 2024
IPO Bidding Closes
05 Jul 2024
Allotment & Refunds
Completed
Exchange Listing Day
10 Jul 2024

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 67.87x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)195.83x
Non-Institutional Investors (NII / HNI)48.32x
Retail Individual Investors (RII)7.21x
Employees Reservation8.81x
Total Subscription67.87x
Updated as on 05-Jul-2024 19:00:00

Listing Day & Return Performance

Listing Day Gain+31.45%
₹1,008 (Issue) → ₹1,325.05 (List)
Per share profit: +₹317.05
Holding Return (Till Date)+75.63%
₹1,008 (Issue) → ₹1,770.40 (CMP)
Net gain per share: +₹762.40
Post-Listing Performance (Listing Day → Today):+33.61%

About Emcure Pharmaceuticals Limited IPO

Emcure Pharmaceuticals Limited is an Indian public offering categorized under the Mainboard segment. The public issue opened for bidding on 03 Jul 2024 and concluded on 05 Jul 2024, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹960 - ₹1008.

During the bidding window, Emcure Pharmaceuticals Limited witnessed heavy demand with an overall subscription of 67.87 times. Institutional investors (QIB) subscribed 195.83x, non-institutional high-net-worth investors (NII) subscribed 48.32x, and retail individual investors (RII) bid 7.21x their reserved quota, alongside employee participation of 8.81x.

The equity shares of Emcure Pharmaceuticals Limited officially debuted on the stock exchanges on 10 Jul 2024 at an opening listing price of ₹1,325.05, delivering a listing day return of +31.45% (premium) over the final issue price. As per the latest market data, the stock trades at ₹1,770.40, representing an overall gain of +75.63% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Emcure Pharmaceuticals Limited IPO?
The issue price of Emcure Pharmaceuticals Limited IPO was fixed at ₹1,008 per equity share. The indicative bidding price band was ₹960 - ₹1008.
What were the open, close, and listing dates for Emcure Pharmaceuticals Limited IPO?
Emcure Pharmaceuticals Limited IPO opened on 03 Jul 2024, closed on 05 Jul 2024, listed on 10 Jul 2024.
How much was Emcure Pharmaceuticals Limited IPO subscribed?
The IPO received an overall subscription of 67.87 times. Category-wise, QIBs subscribed 195.83x, NIIs subscribed 48.32x, and Retail investors subscribed 7.21x.
What was the listing price and listing gain of Emcure Pharmaceuticals Limited IPO?
Emcure Pharmaceuticals Limited IPO listed on the stock exchange at ₹1,325.05, delivering a listing gain of 31.45% compared to the IPO issue price of ₹1,008.
Is Emcure Pharmaceuticals Limited IPO a Mainboard or SME IPO?
Emcure Pharmaceuticals Limited IPO is a Mainboard IPO listed on the main exchange of NSE.
What is the current return of Emcure Pharmaceuticals Limited IPO since its IPO?
At the latest market quote of ₹1,770.40, Emcure Pharmaceuticals Limited IPO has generated an all-time return of +75.63% since its initial public offering.

Related Mainboard IPOs (2024)

UNIMECH
Unimech Aerospace and Manufacturing Limited
₹785+85.99%
VENTIVE
Ventive Hospitality Limited
₹643+11.35%
CARRARO
Carraro India Limited
₹704-7.53%
SENORES
Senores Pharmaceuticals Limited
₹391+53.45%